Trial Profile
A Randomized, Double-Blind, Double-Dummy, Multi-Centre, 4-Way Cross-Over Study to Compare the Single Dose Bronchodilatory Effect of Formoterol Fumarate in Combination With Mometasone Furoate Delivered Via Pressurized Metered Dose Inhaler (pMDI) to Placebo Delivered Via pMDI in Children Aged 5-11 Years Old With Persistent Asthma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Mometasone/formoterol (Primary) ; Formoterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Novartis
- 13 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Mar 2009 Planned number of patients changed from 30 to 32 as reported by ClinicalTrials.gov.